JPMorgan Downgrades Teva Pharma (TEVA) to Underweight

November 4, 2013 6:48 AM

JPMorgan downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underweight with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found